M

Metabiomed Co Ltd
KOSDAQ:059210

Watchlist Manager
Metabiomed Co Ltd
KOSDAQ:059210
Watchlist
Price: 4 855 KRW 1.04% Market Closed
Market Cap: 136.4B KRW

Wall Street
Price Targets

Price Targets Summary
Metabiomed Co Ltd

There are no price targets for Metabiomed Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Metabiomed Co Ltd Competitors:
Price Targets
688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
42% Upside
2276
Shanghai Conant Optical Co Ltd
8% Upside
ALGN
Align Technology Inc
16% Upside
SDI
SDI Ltd
37% Upside
CERS
Cerus Corp
131% Upside
6491
Pegavision Corp
26% Upside
300888
Winner Medical Co Ltd
53% Upside
1066
Shandong Weigao Group Medical Polymer Co Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
Metabiomed Co Ltd

For the last 13 years the compound annual growth rate for Metabiomed Co Ltd's revenue is 10%. The projected CAGR for the next 3 years is 19%.

10%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Metabiomed Co Ltd

For the last 13 years the compound annual growth rate for Metabiomed Co Ltd's operating income is 13%. The projected CAGR for the next 3 years is 31%.

13%
Past Growth
31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Metabiomed Co Ltd

For the last 13 years the compound annual growth rate for Metabiomed Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 14%.

25%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Metabiomed Co Ltd's stock price target?
Not Available

Metabiomed Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Metabiomed Co Ltd's Revenue forecast?
Projected CAGR
19%

For the last 13 years the compound annual growth rate for Metabiomed Co Ltd's revenue is 10%. The projected CAGR for the next 3 years is 19%.

What is Metabiomed Co Ltd's Operating Income forecast?
Projected CAGR
31%

For the last 13 years the compound annual growth rate for Metabiomed Co Ltd's operating income is 13%. The projected CAGR for the next 3 years is 31%.

What is Metabiomed Co Ltd's Net Income forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Metabiomed Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 14%.

Back to Top